✦ LIBER ✦

Phase II Clinical Trial of Didemnin B in Patients with Recurrent or Refractory Anaplastic Astrocytoma or Glioblastoma Multiforme (NSC 325319)

✍ Scribed by Abraham Mittelman; Hoo G. Chun; Carmelo Puccio; Nancy Coombe; Thomas Lansen; Tauseef Ahmed

Book ID: 110234781
Publisher: Springer US
Year: 1999
Tongue: English
Weight: 37 KB
Volume: 17
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1006379402114

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II trial of paclitaxel and topot

A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma

✍ J. Marc Pipas; Louise P. Meyer; C. Harker Rhodes; Laurence D. Cromwell; Carol E. 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 286 KB

Brentuximab Vedotin (SGN-35) in Patients

Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

✍ Pro, B.; Advani, R.; Brice, P.; Bartlett, N. L.; Rosenblatt, J. D.; Illidge, T.; 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 395 KB

Evaluation of Monoclonal Humanized Anti-

Evaluation of Monoclonal Humanized Anti-HER2 Antibody, Trastuzumab, in Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Carcinoma With Overexpression of HER2: A Phase II Trial of the Gynecologic Oncology Group

✍ Bookman, M. A. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 108 KB

Treatment of Progressive or Recurrent Gl

Treatment of Progressive or Recurrent Glioblastoma Multiforme in Adults with Herpes Simplex Virus Thymidine Kinase Gene Vector-Producer Cells Followed by Intravenous Ganciclovir Administration: A Phase I/II Multi-Institutional Trial

✍ Michael D. Prados; Michael McDermott; Susan M. Chang; Charles B. Wilson; James F 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 81 KB

Gemcitabine, dexamethasone, and cisplati

Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma : A Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)

✍ Michael Crump; Tara Baetz; Stephen Couban; Andrew Belch; Deborah Marcellus; Kang 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

Bendamustine Combined With Rituximab in

Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Stilgenbauer, S.; Bahlo, J.; Schweighofer, C 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 141 KB